By Adriano MarcheseRevolution Medicines reported early trial results showed that its experimental drug zoldonrasib produced strong antitumor activity in two combination regimens for patients with metastatic pancreatic cancer.The late-stage clinical oncology company said Thursday that its drug zoldo…
(12:39 GMT) Amass Brands Price Target Announced at $7.00/Share by Maxim Group
SINGAPORE, July 2, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE:CYD) ("China Yuchai International"), announced today that a cash dividend of US$0.87 per ordinary share for the year ended December 31, 2025 has been declared by its Board of Directors. The cash dividend will be paid o…
WASHINGTON (dpa-AFX) - Fresh scientific evidence and options for harnessing artificial intelligence were unveiled Wednesday following the launch of the first global, independent scientific assessment of opportunities, risks and impacts by a pioneering UN expert panel.'The science is here,' UN Secre…
Zacks Investment Research has recently initiated coverage of Valhi, Inc. VHI with an “Underperform” recommendation, citing persistent challenges in the company's core Chemicals business that could continue to weigh on earnings and limit upside potential.Valhi is a diversified holding company with o…
By Kelly CloonanClearOne plans to merge with Vivani Medical's brain implant device subsidiary Cortigent.Under the deal, Vivani would receive 12.5 million shares of ClearOne common stock as consideration for all of the issued and outstanding shares of Cortigent, giving it a stake in the combined com…
(12:35 GMT) Coherent Price Target Raised to $435.00/Share From $371.00 by Raymond James
(12:35 GMT) GE Aerospace Price Target Raised to $455.00/Share From $365.00 by Jefferies
Arcturus Therapeutics Holdings Inc NASDAQ:ARCT:
HOUSTON--(BUSINESS WIRE)--July 02, 2026--Chevron Corporation NYSE:CVX, one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, July 31, 2026 at 11:00 a.m. ET (10:00 a.m. CT).Conference Call Information:Date: Friday, July 31, 2026Time: 11:00 a.m. ET…
ATLANTA--(BUSINESS WIRE)--July 02, 2026--Ameris Bancorp NYSE:ABCB (the "Company") announced today that it intends to release its second quarter 2026 financial results in a press release after the market closes on Thursday, July 23, 2026. H. Palmer Proctor, Jr., Chief Executive Officer, Nicole S. St…
(12:30 GMT) *Rivian Automotive Produced 12,613 Vehicles at Its Manufacturing Facility in Normal, Illinois in 2Q >RIVN (12:30 GMT) *Rivian Automotive Delivered 12,194 Vehicles During 2Q >RIVN (12:31 GMT) *Rivian Automotive Is Today Raising Its Full Yr 2026 Delivery Guidance From 62,000 - 67,000 Vehi…
Columbia Financial announced stockholder and depositor approvals for its second‑step conversion and $1.1 billion in subscription orders.Key Highlights:Original SEC Filing: Columbia Financial, Inc. [ CLBK ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ver…
On July 1, 2026, Nasdaq notified the company it remains out of compliance with the $1.00 minimum bid price under Listing Rule 5550(a)(2) and granted a second 180-day period until Dec 28, 2026 to regain compliance. The stock will be deemed compliant if the bid is at least $1.00 for 10 consecutive bu…
Rivian Automotive reported Q2 production of 12,613 vehicles and deliveries of 12,194, and raised its full-year 2026 delivery outlook.Key Highlights:Original SEC Filing: Rivian Automotive, Inc. / DE [ RIVN ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ve…
VisionWave appointed Stratonex as its strategic UK and European commercialization and sovereign delivery partner under a two-year distributor agreement.Key Highlights:Original SEC Filing: VisionWave Holdings, Inc. [ VWAV ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccurac…
(12:33 GMT) Knight-Swift Transport Price Target Raised to $91.00/Share From $76.00 by Raymond James
Lixte Biotechnology: to Trade as NMAD Effective July 6 >LIXT
Dow Inc.’s DOW shares have gained 15.5% so far this year. It has been gaining from its cost-reduction and productivity improvement efforts, strategic expansion in high-growth markets and feedstock advantages in the Americas, even as it navigates a challenging macroeconomic environment.Dow has perfo…
Investors generally tend to cling to the price-to-earnings (P/E) metric while looking for bargain stocks. In addition to being a widely used tool for screening stocks, P/E is also a popular metric to work out the fair market value of a company. But even this ubiquitously used valuation multiple has…
